Description
Fulvest 250mg Injection is a medication used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Its active ingredient is Fulvestrant, a selective estrogen receptor degrader (SERD). Fulvestrant works by blocking the action of estrogen and promoting the breakdown of estrogen receptors in breast cancer cells. This helps to slow or stop the growth of estrogen-dependent tumors. Fulvest 250mg Injection is administered by a healthcare professional. The typical dosage is 500mg (two 250mg injections, one in each buttock) administered on days 0, 14, and 28, and then once every 28 days thereafter. Common side effects may include hot flashes, nausea, fatigue, injection site reactions, and pain. It is important to discuss any potential side effects with your doctor. Store Fulvest 250mg Injection at room temperature, away from light and moisture.
